Innostellar Biotherapeutics Co.,Ltd
6 clinical trials · Sponsor
◉ Watch Innostellar Biotherapeutics Co.,Ltd
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR) (NCT07317934) | Innostellar Biotherapeutics Co.,Ltd | 2026-01-14 |
| Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS) (NCT06196840) | Innostellar Biotherapeutics Co.,Ltd | 2024-01-24 |
| Efficacy and Safety of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations (NCT07054632) | Innostellar Biotherapeutics Co.,Ltd | 2023-09-13 |
| Fellow-eye Study (FE) of LX101 in Subjects With Inherited Retinal Dystrophy (NCT06212297) | Innostellar Biotherapeutics Co.,Ltd | 2023-09-12 |
| LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD) (NCT06198413) | Innostellar Biotherapeutics Co.,Ltd | 2023-02-27 |
| Safety and Tolerability of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations (NCT06196827) | Innostellar Biotherapeutics Co.,Ltd | 2022-07-02 |
Track Innostellar Biotherapeutics Co.,Ltd automatically
Every clearance here is in the API, with alerts when new ones post.